Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia - PubMed (original) (raw)
Review
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia
H Y Meltzer. Psychopharmacology (Berl). 1989.
Abstract
Clozapine administration to schizophrenic patients was found to produce dopamine2 (D-2) and serotonin2 (5-HT2) receptor blockade, as evidenced by the ability to block the increases in growth hormone and cortisol secretion produced by apomorphine and MK-212, respectively, direct acting dopamine (DA) and 5-HT2 agonists. Clozapine did not increase plasma prolactin (PRL) levels nor did it block the apomorphine-induced decrease in plasma PRL concentration, as would be expected from a D-2 receptor antagonist. These PRL results are consistent with the observation that clozapine may increase DA release. Clozapine also decreased plasma tryptophan, plasma homovanillac acid (HVA) and basal plasma cortisol levels. Rodent studies suggest clozapine also increases 5-HT release. We hypothesize that antagonism of D-2 and 5-HT2 receptors and enhancement of DA and 5-HT release are critical elements in the action of clozapine to minimize both positive and negative symptoms without producing significant extrapyramidal symptoms or plasma PRL increases. It is proposed that schizophrenia may also involve a dysregulation of 5-HT2- and D-2-mediated neurotransmission, and that a more normal balance in serotonergic and dopaminergic neurotransmission is at least partially restored by clozapine.
Similar articles
- Clozapine: new research on efficacy and mechanism of action.
Meltzer HY, Bastani B, Ramirez L, Matsubara S. Meltzer HY, et al. Eur Arch Psychiatry Neurol Sci. 1989;238(5-6):332-9. doi: 10.1007/BF00449814. Eur Arch Psychiatry Neurol Sci. 1989. PMID: 2569975 Review. - The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.
Meltzer HY, Maes M, Lee MA. Meltzer HY, et al. Psychopharmacology (Berl). 1993;112(1 Suppl):S95-104. doi: 10.1007/BF02245013. Psychopharmacology (Berl). 1993. PMID: 7831446 Clinical Trial. - Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
Nair NP, Lal S, Cervantes P, Yassa R, Guyda H. Nair NP, et al. Neuropsychobiology. 1979;5(3):136-42. doi: 10.1159/000117675. Neuropsychobiology. 1979. PMID: 431802 - Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.
Meltzer HY, Gudelsky GA. Meltzer HY, et al. Arzneimittelforschung. 1992 Feb;42(2A):268-72. Arzneimittelforschung. 1992. PMID: 1586397 Review. - Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal.
Bürki HR, Eichenberger E, Sayers AC, White TG. Bürki HR, et al. Pharmakopsychiatr Neuropsychopharmakol. 1975 May;8(3):115-21. doi: 10.1055/s-0028-1094449. Pharmakopsychiatr Neuropsychopharmakol. 1975. PMID: 1241920
Cited by
- Neurobiochemical Disturbances in Psychosis and their Implications for Therapeutic Intervention.
Panov G, Panova P. Panov G, et al. Curr Top Med Chem. 2024;24(20):1784-1798. doi: 10.2174/0115680266282773240116073618. Curr Top Med Chem. 2024. PMID: 38265370 Review. - Correlations between omega-3 fatty acids and inflammatory/glial abnormalities: the involvement of the membrane and neurotransmitter dysfunction in schizophrenia.
Zhang Y, Yin J, Yan H, Yan L, Li Y, Zhang C, Li Y, Liu B, Lin J, Zhang L, Hu X, Song C. Zhang Y, et al. Front Cell Neurosci. 2023 Oct 23;17:1163764. doi: 10.3389/fncel.2023.1163764. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37937262 Free PMC article. - Excitatory and inhibitory imbalances in the trisynaptic pathway in the hippocampus in schizophrenia: a postmortem ultrastructural study.
Farmer CB, Roach EL, Bice LR, Falgout ME, Mata KG, Roche JK, Roberts RC. Farmer CB, et al. J Neural Transm (Vienna). 2023 Jul;130(7):949-965. doi: 10.1007/s00702-023-02650-5. Epub 2023 May 16. J Neural Transm (Vienna). 2023. PMID: 37193867 - The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI.
Cushnie AK, Bullock DN, Manea AMG, Tang W, Zimmermann J, Heilbronner SR. Cushnie AK, et al. Curr Res Neurobiol. 2022 Dec 30;4:100072. doi: 10.1016/j.crneur.2022.100072. eCollection 2023. Curr Res Neurobiol. 2022. PMID: 36691404 Free PMC article. - The serum metabolomic profile of a distinct, inflammatory subtype of acute psychosis.
Lennox B, Xiong W, Waters P, Coles A, Jones PB, Yeo T, May JTM, Yeeles K, Anthony D, Probert F. Lennox B, et al. Mol Psychiatry. 2022 Nov;27(11):4722-4730. doi: 10.1038/s41380-022-01784-4. Epub 2022 Sep 21. Mol Psychiatry. 2022. PMID: 36131046 Free PMC article.
References
- Br Med J. 1980 Jan 12;280(6207):66-8 - PubMed
- Arch Gen Psychiatry. 1988 Sep;45(9):865-7 - PubMed
- J Clin Psychopharmacol. 1982 Oct;2(5):336-40 - PubMed
- Arch Gen Psychiatry. 1988 Sep;45(9):789-96 - PubMed
- Psychopharmacology (Berl). 1989;99 Suppl:S28-31 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical